drugset / Trial / NCT05459493

A Clinical Study of Chinese Herbal Compound TJAOA101 in Therapy of Diminished Ovarian Reserve

NCT05459493 ↗

Phase 0 Unknown 100 enrolled Tongji Hospital
NaSingle-groupOpen-labelTreatment

Summary

Currently, no drugs have been developed for DOR. We developed the Chinese herbal compound TJAOA101 and has validated its effects in animals. Here, we will perform a population-based, multicenter study to confirm the safety and efficacy of TJAOA101 in therapy of DOR. We aim to provide a solid evidence for TCM in therapy of DOR.

Timeline

Start
2022-11-01
Primary completion
2023-11-01
Completion
2023-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject TJAOA101 Traditional medicine (herbal / TCM) — Oral

Indications